{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T13:01:25Z","timestamp":1778504485589,"version":"3.51.4"},"reference-count":51,"publisher":"Institute of Physiology of the Czech Academy of Sciences","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Physiol Res"],"abstract":"<jats:p>Gestational diabetes mellitus (GDM) is a common complication of pregnancy in which women without previously diagnosed diabetes develop chronic hyperglycemia during pregnancy. It is associated with a number of maternal and fetal\/neonatal complications. The role of the adipokines retinol binding protein-4, resistin and nesfatin-1 in the development of GDM is relatively poorly understood, but their role in glucose metabolism is suspected and their use as early markers to predict the development of GDM is being sought. The aim of study was to determine the correlation between the levels of selected adipokines (retinol binding protein-4, resistin, nesfatin-1) in women with gestational diabetes mellitus (GDM) and healthy pregnant women and to compare their levels with other clinical and biochemical parameters. Patients with GDM had significantly higher BMI (28.4\u00b14.5 vs. 24.6\u00b14 kg\/m2), total cholesterol (6\u00b11.3 vs. 5.3\u00b11.4 mmol\/l) and triacylglycerols (1.9\u00b10.8 vs. 1.4\u00b10.7 mmol\/l) than women in the control group. RBP4 confirms the significant difference between the groups, it is higher in the control group of healthy pregnant women. The adipokines resistin and nesfatin-1 show no differences between the control and GDM groups, but their ratios with BMI, cholesterol and triacylglycerols, resistin shows elevated levels in the control group. In women with GDM, RBP4 was significantly positively correlated with C-peptide and negatively correlated with total, LDL, and non-HDL cholesterol. Resistin was also negatively correlated with total, LDL, HDL, and non-HDL cholesterol. Nesfatin-1 was only moderately positively correlated with glycated hemoglobin (HbA1C) and fasting glycemia.There is ambiguity in the results of previous studies on the levels of the investigated adipokines in pregnant women with GDM and the interpretation depends on many factors.\n\nKeywords: Gestational diabetes \u2022 Adipokines \u2022 Retinol-binding protein 4 \u2022 Resistin \u2022 Nesfatin-1<\/jats:p>","DOI":"10.33549\/physiolres.935412","type":"journal-article","created":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T12:51:40Z","timestamp":1738414300000},"page":"1037-1048","source":"Crossref","is-referenced-by-count":4,"title":["Adipokine Levels of RBP4, Resistin and Nesfatin-1 in Women Diagnosed With Gestational Diabetes"],"prefix":"10.33549","author":[{"given":"V","family":"Ku\u010derov\u00e1","sequence":"first","affiliation":[{"name":"Department of Clinical Biochemistry, University Hospital Olomouc, Czech Republic. Veronika.Kucerova@fnol.cz"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D","family":"Kar\u00e1sek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O","family":"Krystyn\u00edk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L","family":"\u0160tefani\u010dkov\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V","family":"N\u011bme\u010dek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D","family":"Friedeck\u00fd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"19169","published-online":{"date-parts":[[2024,12,31]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","unstructured":"Hill M, Parizek A, Simjak P, Koucky M, Anderlova K, Krejci H, et al. Steroids, Steroid Associated Substances and Gestational Diabetes Mellitus. Physiol Res 2021;70:S617-S634. https:\/\/doi.org\/10.33549\/physiolres.934794","DOI":"10.33549\/physiolres.934794"},{"key":"ref1","doi-asserted-by":"publisher","unstructured":"Simjak P, Cinkajzlova A, Anderlova K, Parizek A, Mraz M, Krsek M, et al. The role of obesity and adipose tissue dysfunction in gestational diabetes mellitus. J Endocrinol 2018;238:R63-R77. https:\/\/doi.org\/10.1530\/JOE-18-0032","DOI":"10.2337\/db18-1413-p"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"Mallardo M, Ferraro S, Daniele A, Nigro E. GDM-Complicated Pregnancies: Focus on Adipokines. Molecular Biology Reports, vol. 48, no. 12, Springer Science and Business Media LLC, 2021, pp. 8171-8180. https:\/\/doi.org\/10.1007\/s11033-021-06785-0","DOI":"10.1007\/s11033-021-06785-0"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"Cibickova L, Grega M, Dohnal R, Schovanek J. Effect of laparoscopic sleeve gastrectomy on serum adipokine levels. Physiol Res 2023;72:S165-S172. https:\/\/doi.org\/10.33549\/physiolres.935053","DOI":"10.33549\/physiolres.935053"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"Korek E, Krauss H. Novel adipokines: their potential role in the pathogenesis of obesity and metabolic disorders. Postepy Hig Med Dosw. 2015;69:799-810. https:\/\/doi.org\/10.5604\/17322693.1161415","DOI":"10.5604\/17322693.1161415"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"de Gennaro G, Palla G, Battini L, Simoncini T, Del Prato S, Bertolotto A, et al. The role of adipokines in the pathogenesis of gestational diabetes mellitus. Gynecol Endocrinol. 2019;35:737-751. https:\/\/doi.org\/10.1080\/09513590.2019.1597346","DOI":"10.1080\/09513590.2019.1597346"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"Nava-Salazar S, Flores-Pliego A, P\u00e9rez-Mart\u00ednez G, Parra-Hern\u00e1ndez S, Vanoye-Carlo A, Ibarguengoitia-Ochoa F, et al. Resistin modulates low-density lipoprotein cholesterol uptake in human placental explants via PCSK9. Reprod Sci. 2022;29:3242-3253. https:\/\/doi.org\/10.1007\/s43032-022-00943-w","DOI":"10.1007\/s43032-022-00943-w"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"G\u00f6rkem \u00dc, K\u00fc\u00e7\u00fckler FK, To\u011frul C, G\u00fcng\u00f6r T. Are adipokines associated with gestational diabetes mellitus? J Turk Ger Gynecol Assoc. 2016;17:186-190. https:\/\/doi.org\/10.5152\/jtgga.2016.16112","DOI":"10.5152\/jtgga.2016.16112"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"Steinhoff JS, Lass A, Schupp M. Biological Functions of RBP4 and its relevance for human diseases. Front Physiol. 2021;12:659977. https:\/\/doi.org\/10.3389\/fphys.2021.659977","DOI":"10.3389\/fphys.2021.659977"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"Graham TE, Yang Q, Bl\u00fcher M, Hammarstedt A, Ciaraldi TP, Henry RR, et al. Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects. N Engl J Med. 2006;354:2552-2563. https:\/\/doi.org\/10.1056\/NEJMoa054862","DOI":"10.1056\/nejmoa054862"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"Abel ED, Peroni O, Kim JK, Kim YB, Boss O, Hadro E, et al. Adipose-selective targeting of the GLUT4 gene impairs insulin action in muscle and liver. Nature. 2001;409: 729-733. https:\/\/doi.org\/10.1038\/35055575","DOI":"10.1038\/35055575"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"Wolf G. Serum retinol-binding protein: a link between obesity, insulin resistance, and type 2 diabetes. Nutr Rev. 2007;65:251-256. https:\/\/doi.org\/10.1111\/j.1753-4887.2007.tb00302.x","DOI":"10.1111\/j.1753-4887.2007.tb00302.x"},{"key":"ref12","unstructured":"Kopff B, Jegier A. Adipokines: adiponectin, leptin, resistin and coronary heart disease risk. Przegl Lek 2005;62 (S3): 69-72."},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"Sato N, Kobayashi K, Inoguchi T, Sonoda N, Imamura M, Sekiguchi N, et al. Adenovirus-mediated high expression of resistin causes dyslipidemia in mice. Endocrinology. 2005;146:273-279. https:\/\/doi.org\/10.1210\/en.2004-0985","DOI":"10.1210\/en.2004-0985"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"McTernan CL, McTernan P, Harte AL, Levick PL, Barnett AH, Kumar S. Resistin, central obesity, and type 2 diabetes. Lancet. 2002;359:46-47. https:\/\/doi.org\/10.1016\/S0140-6736(02)07281-1","DOI":"10.1016\/s0140-6736(02)07281-1"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"Sch\u00e4ffler A, B\u00fcchler C, M\u00fcller-Ladner U, Herfarth H, Ehling A, Paul G, et al. Identification of variables influencing resistin serum levels in patients with type 1 and type 2 diabetes mellitus. Horm Metab Res 2004;36:702-707. https:\/\/doi.org\/10.1055\/s-2004-826015","DOI":"10.1055\/s-2004-826015"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"Vendrell J, Broch M, Vilarrasa N, Molina A, G\u00f3mez JM, Guti\u00e9rrez C, et al. Resistin, adiponectin, ghrelin, leptin, and proinflammatory cytokines: relationships in obesity. Obes Res. 2004;12:962-971. https:\/\/doi.org\/10.1038\/oby.2004.118","DOI":"10.1038\/oby.2004.118"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"Abaci A, Catli G, Anik A, Kume T, Bober E. The relation of serum nesfatin-1 level with metabolic and clinical parameters in obese and healthy children. Pediatr Diabetes. 2013;14:189-195. https:\/\/doi.org\/10.1111\/pedi.12009","DOI":"10.1111\/pedi.12009"},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"Ramanjaneya M, Chen J, Brown JE, Tripathi G, Hallschmid M, Patel S, et al. Identification of Nesfatin-1 in human and murine adipose tissue: a novel depot-specific adipokine with increased levels in obesity. Endocrinology. 2010;151:3169-3180. https:\/\/doi.org\/10.1210\/en.2009-1358","DOI":"10.1210\/en.2009-1358"},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"Hofmann T, Stengel A, Ahnis A, Bu\u03b2e P, Elbelt U, Klapp BF. NUCB2\/nesfatin-1 is associated with elevated scores of anxiety in female obese patients. Psychoneuroendocrinology 2013;38:2502-2510. https:\/\/doi.org\/10.1016\/j.psyneuen.2013.05.013","DOI":"10.1016\/j.psyneuen.2013.05.013"},{"key":"ref20","doi-asserted-by":"crossref","unstructured":"Su Y, Zhang J, Tang Y, Bi F, Liu JN. The novel function of nesfatin-1: Anti-hyperglycemia. Biochem Biophys Res Commun. 2010;391:1039-1042. https:\/\/doi.org\/10.1016\/j.bbrc.2009.12.014","DOI":"10.1016\/j.bbrc.2009.12.014"},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"Karasek D, Krystynik O, Kucerova V, Macakova D, Cibickova L, Schovanek J, et al. Adiponectin, A-FABP and FGF-19 Levels in Women with Early Diagnosed Gestational Diabetes. J Clin Med Res 2022;11:2417. https:\/\/doi.org\/10.3390\/jcm11092417","DOI":"10.3390\/jcm11092417"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"American Diabetes Association Professional Practice Committee. 2. Diagnosis and classification of diabetes: standards of care in diabetes-2024. Diabetes Care 2024;47:S20-S42. https:\/\/doi.org\/10.2337\/dc24-S002","DOI":"10.2337\/dc22-s002"},{"key":"ref23","doi-asserted-by":"publisher","unstructured":"Retnakaran R, Hanley AJG, Connelly PW, Sermer M, Zinman B. Ethnicity modifies the effect of obesity on insulin resistance in pregnancy: a comparison of Asian, South Asian, and Caucasian women. J Clin Endocrinol Metab. 2006;91:93-97. https:\/\/doi.org\/10.1210\/jc.2005-1253","DOI":"10.1210\/jc.2005-1253"},{"key":"ref24","doi-asserted-by":"publisher","unstructured":"Wang MN, Han YB, Li Q, Guo L, Yang YM, Wang W, et al. Higher serum retinol binding protein 4 may be a predictor of weak metabolic control in chinese patients with type 2 diabetes mellitus. J Int Med Res. 2012;40:1317-1324. https:\/\/doi.org\/10.1177\/147323001204000410","DOI":"10.1177\/147323001204000410"},{"key":"ref25","doi-asserted-by":"publisher","unstructured":"Du X, Dong Y, Xiao L, Liu G-H, Qin W, Yu H. Association between retinol-binding protein 4 concentrations and gestational diabetes mellitus (A1GDM and A2GDM) in different pregnancy and postpartum periods. Ann Transl Med. 2019;7:479. https:\/\/doi.org\/10.21037\/atm.2019.08.45","DOI":"10.21037\/atm.2019.08.45"},{"key":"ref26","doi-asserted-by":"publisher","unstructured":"Khovidhunkit W, Pruksakorn P, Plengpanich W, Tharavanij T. Retinol-binding protein 4 is not associated with insulin resistance in pregnancy. Metabolism. 2012;61:65-69. https:\/\/doi.org\/10.1016\/j.metabol.2011.05.019","DOI":"10.1016\/j.metabol.2011.05.019"},{"key":"ref27","doi-asserted-by":"publisher","unstructured":"Tepper BJ, Kim Y-K, Shete V, Shabrova E, Quadro L. Serum retinol-binding protein 4 (RBP4) and retinol in a cohort of borderline obese women with and without gestational diabetes. Clin Biochem. 2010;43:320-323. https:\/\/doi.org\/10.1016\/j.clinbiochem.2009.10.013","DOI":"10.1016\/j.clinbiochem.2009.10.013"},{"key":"ref28","doi-asserted-by":"publisher","unstructured":"Krzyzanowska K, Zemany L, Krugluger W, Schernthaner GH, Mittermayer F, Schnack C, et al. Serum concentrations of retinol-binding protein 4 in women with and without gestational diabetes. Diabetologia. 2008;51: 1115-1122. https:\/\/doi.org\/10.1007\/s00125-008-1009-9","DOI":"10.1007\/s00125-008-1009-9"},{"key":"ref29","doi-asserted-by":"publisher","unstructured":"Fruscalzo A, Londero AP, Driul L, Henze A, Tonutti L, Ceraudo M, et al. First trimester concentrations of the TTR-RBP4-retinol complex components as early markers of insulin-treated gestational diabetes mellitus. Clin Chem Lab Med. 2015;53:1643-1651. https:\/\/doi.org\/10.1515\/cclm-2014-0929","DOI":"10.1515\/cclm-2014-0929"},{"key":"ref30","doi-asserted-by":"publisher","unstructured":"Fan J, Hu J. Retinol binding protein 4 and type 2 diabetes: from insulin resistance to pancreatic \u03b2-cell function. Endocrine. 2024;85: 1020-1034. https:\/\/doi.org\/10.1007\/s12020-024-03777-5","DOI":"10.1007\/s12020-024-03777-5"},{"key":"ref31","doi-asserted-by":"publisher","unstructured":"Huang R, Bai X, Li X, Wang X, Zhao L. Retinol-Binding Protein 4 Activates STRA6, Provoking Pancreatic \u03b2-Cell Dysfunction in Type 2 Diabetes. Diabetes 2021;70. https:\/\/doi.org\/10.2337\/db19-1241","DOI":"10.2337\/figshare.13200527.v1"},{"key":"ref32","doi-asserted-by":"publisher","unstructured":"Feng S, Zhu Y, Yan C, Wang Y, Zhang Z. Retinol binding protein 4 correlates with and is an early predictor of carotid atherosclerosis in type 2 diabetes mellitus patients. J Biomed Res 2015;29:451-455. https:\/\/doi.org\/10.7555\/JBR.29.20140087","DOI":"10.7555\/jbr.29.20140087"},{"key":"ref33","doi-asserted-by":"publisher","unstructured":"Liu C, Zhou X-R, Ye M-Y, Xu X-Q, Zhang Y-W, Liu H, et al. RBP4 Is associated with insulin resistance in hyperuricemia-induced rats and patients with hyperuricemia. Front Endocrinol 2021;12:653819. https:\/\/doi.org\/10.3389\/fendo.2021.653819","DOI":"10.3389\/fendo.2021.653819"},{"key":"ref34","doi-asserted-by":"publisher","unstructured":"Wang S-N, Yeh Y-T, Wang S-T, Chen Y-L, Chuang S-C, Ker C-G, et al. Decreased retinol binding protein 4 concentrations are associated with cholesterol gallstone disease. J Formos Med Assoc 2010;109:422-429. https:\/\/doi.org\/10.1016\/S0929-6646(10)60073-3","DOI":"10.1016\/s0929-6646(10)60073-3"},{"key":"ref35","doi-asserted-by":"publisher","unstructured":"Kallol S, Albrecht C. Materno-fetal cholesterol transport during pregnancy. Biochem Soc Trans. 2020;48:775-786. https:\/\/doi.org\/10.1042\/BST20190129","DOI":"10.1042\/bst20190129"},{"key":"ref36","doi-asserted-by":"publisher","unstructured":"Cibickova L, Langova K, Schovanek J, Macakova D, Krystynik O, Karasek D. Pregnancy Lipid Profile and Different Lipid Patterns of Gestational Diabetes Treated by Diet Itself. Physiological Research 2022;71:241-248. https:\/\/doi.org\/10.33549\/physiolres.934835","DOI":"10.33549\/physiolres.934835"},{"key":"ref37","doi-asserted-by":"publisher","unstructured":"Chen D, Dong M, Fang Q, He J, Wang Z, Yang X. Alterations of serum resistin in normal pregnancy and pre-eclampsia. Clin Sci 2005;108:81-84. https:\/\/doi.org\/10.1042\/CS20040225","DOI":"10.1042\/cs20040225"},{"key":"ref38","doi-asserted-by":"publisher","unstructured":"Yura S, Sagawa N, Itoh H, Kakui K, Nuamah MA, Korita D, et al. Resistin Is Expressed in the Human Placenta. J Clin Endocrinol Metab 2003;88:1394-1397. https:\/\/doi.org\/10.1210\/jc.2002-011926","DOI":"10.1210\/jc.2002-011926"},{"key":"ref39","doi-asserted-by":"publisher","unstructured":"Janowska J, Zahorska-Markiewicz B, Olszanecka-Glinianowicz M. Relationship between serum resistin concentration and proinflammatory cytokines in obese women with impaired and normal glucose tolerance. Metabolism. 2006;55:1495-1499. https:\/\/doi.org\/10.1016\/j.metabol.2006.06.020","DOI":"10.1016\/j.metabol.2006.06.020"},{"key":"ref40","doi-asserted-by":"publisher","unstructured":"Osorio-Conles \u00d3, Vidal J, de Hollanda A. Impact of bariatric surgery on adipose tissue biology. J Clin Med Res. 2021;10:5516. https:\/\/doi.org\/10.3390\/jcm10235516","DOI":"10.3390\/jcm10235516"},{"key":"ref41","doi-asserted-by":"publisher","unstructured":"Wadsack C, Tabano S, Maier A, Hiden U, Alvino G, Cozzi V, et al. Intrauterine growth restriction is associated with alterations in placental lipoprotein receptors and maternal lipoprotein composition. Am J Physiol Endocrinol Metab. 2007;292:E476-E484. https:\/\/doi.org\/10.1152\/ajpendo.00547.2005","DOI":"10.1152\/ajpendo.00547.2005"},{"key":"ref42","doi-asserted-by":"publisher","unstructured":"Ademoglu EN, Gorar S, Keskin M, Carlioglu A, Ucler R, Erdamar H, et al. Serum nesfatin-1 levels are decreased in pregnant women newly diagnosed with gestational diabetes. Arch Endocrinol Metab. 2017;61:455-459. https:\/\/doi.org\/10.1590\/2359-3997000000288","DOI":"10.1590\/2359-3997000000288"},{"key":"ref43","doi-asserted-by":"publisher","unstructured":"Aslan M, Celik O, Celik N, Turkcuoglu I, Yilmaz E, Karaer A, et al. Cord blood nesfatin-1 and apelin-36 levels in gestational diabetes mellitus. Endocrine 2012;41:424-429. https:\/\/doi.org\/10.1007\/s12020-011-9577-8","DOI":"10.1007\/s12020-011-9577-8"},{"key":"ref44","doi-asserted-by":"publisher","unstructured":"Zhang Y, Lu J-H, Zheng S-Y, Yan J-H, Chen L, Liu X, et al. Serum levels of nesfatin-1 are increased in gestational diabetes mellitus. Gynecol Endocrinol 2017;33:621-624. https:\/\/doi.org\/10.1080\/09513590.2017.1306849","DOI":"10.1080\/09513590.2017.1306849"},{"key":"ref45","doi-asserted-by":"publisher","unstructured":"Sun J, Zhang D, Xu J, Chen C, Deng D, Pan F, et al. Circulating FABP4, nesfatin-1, and osteocalcin concentrations in women with gestational diabetes mellitus: a meta-analysis. Lipids Health Dis. 2020;19: 199. https:\/\/doi.org\/10.1186\/s12944-020-01209-7, https:\/\/doi.org\/10.1186\/s12944-020-01365-w","DOI":"10.1186\/s12944-020-01365-w"},{"key":"ref46","doi-asserted-by":"publisher","unstructured":"Algul S, Ozkan Y, Ozcelik O. Serum nesfatin-1 levels in patients with different glucose tolerance levels. Physiol Res. 2016;65:979-985. https:\/\/doi.org\/10.33549\/physiolres.933186","DOI":"10.33549\/physiolres.933186"},{"key":"ref47","doi-asserted-by":"publisher","unstructured":"Zhang H, Sun T. Correlation of blood glucose and pancreatic islet function with serum retinol-binding protein 4, serum cystatin c, and human new satiety molecule protein-1 in pregnant women with gestational diabetes mellitus. Evid Based Complement Alternat Med. 2022;2022:4247412. https:\/\/doi.org\/10.1155\/2022\/4247412","DOI":"10.1155\/2022\/4247412"},{"key":"ref48","doi-asserted-by":"publisher","unstructured":"Garc\u00e9s MF, Poveda NE, Sanchez E, S\u00e1nchez \u00c1Y, Bravo SB, V\u00e1zquez MJ, et al. Regulation of NucB2\/Nesfatin-1 throughout rat pregnancy. Physiol Behav 2014;133:216-222. https:\/\/doi.org\/10.1016\/j.physbeh.2014.05.042","DOI":"10.1016\/j.physbeh.2014.05.042"},{"key":"ref49","doi-asserted-by":"publisher","unstructured":"Lorenzo-Almor\u00f3s A, Hang T, Peiro C, Soriano-Guillen L, Egido J, Tunon J, et al. Predictive and Diagnostic Biomarkers for Gestational Diabetes and Its Associated Metabolic and Cardiovascular Diseases. Cardiovascular Diabetology, vol. 18, no. 1, Springer Science and Business Media LLC, Oct. 2019, p.140. https:\/\/doi.org\/10.1186\/s12933-019-0935-9","DOI":"10.1186\/s12933-019-0935-9"},{"key":"ref50","doi-asserted-by":"publisher","unstructured":"Gruber M, Brittany L, Dolinsky VW. The role of adiponectin during pregnancy and gestational diabetes. Life (Basel, Switzerland), vol. 13, no. 2, MDPI AG, 2023;p. 301. https:\/\/doi.org\/10.3390\/life13020301","DOI":"10.3390\/life13020301"}],"container-title":["Physiological Research"],"original-title":[],"language":"en","deposited":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T12:51:49Z","timestamp":1738414309000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.biomed.cas.cz\/physiolres\/pdf\/2024\/73_1037.pdf"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,31]]},"references-count":51,"URL":"https:\/\/doi.org\/10.33549\/physiolres.935412","relation":{},"ISSN":["1802-9973","0862-8408"],"issn-type":[{"value":"1802-9973","type":"electronic"},{"value":"0862-8408","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12,31]]}}}